TE
TALOR EYAL Directeur Scientifique
Other M
Insider track record Executive Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by TALOR EYAL, Directeur Scientifique. Director active across 2 companies, notably CEL SCI CORP. Cumulatively, 23 disclosures have been logged. Split: 0 buy · 2 sells. Total volume traded: €290k. Activity tracked since 30 June 2021. The latest transaction was disclosed on 31 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations 23 total
◆ Chief Scientific Officer · Executives · 30 Jun 2026 · CEL SCI CORP 2,307 shares Common Stock SEC:0001238028-26-000003:0
◆ Chief Scientific Officer · Executives · 31 Mar 2025 · CEL SCI CORP 10,416 shares @ US$0.2304 0.7% of flow Common Stock SEC:0001236030-25-000003:0
◆ Chief Scientific Officer · Executives · 31 Dec 2024 · CEL SCI CORP 6,001 shares @ US$0.40 0.7% of flow Common Stock SEC:0001236215-25-000002:0
◆ Chief Scientific Officer · Executives · 30 Sept 2024 · CEL SCI CORP 2,264 shares @ US$1.06 0.6% of flow Common Stock SEC:0001236215-24-000003:0
◆ Chief Scientific Officer · Executives · 28 Jun 2024 · CEL SCI CORP 2,068 shares @ US$1.16 0.7% of flow Common Stock SEC:0001236030-24-000018:0
◆ Chief Scientific Officer · Executives · 29 Mar 2024 · CEL SCI CORP 1,256 shares @ US$1.91 0.7% of flow Common Stock SEC:0001236030-24-000006:0
◆ Chief Scientific Officer · Executives · 29 Dec 2023 · CEL SCI CORP 882 shares @ US$2.72 0.7% of flow Common Stock SEC:0001236030-24-000003:0
◆ Chief Scientific Officer · Executives · 29 Sept 2023 · CEL SCI CORP 1,920 shares @ US$1.25 0.7% of flow Common Stock SEC:0001236030-23-000017:0
◆ Chief Scientific Officer · Executives · 30 Jun 2023 · CEL SCI CORP 995 shares @ US$2.41 0.7% of flow Common Stock SEC:0001236030-23-000006:0
◆ Chief Scientific Officer · Executives · 31 Mar 2023 · CEL SCI CORP 1,034 shares @ US$2.32 0.7% of flow Common Stock SEC:0001236030-23-000003:0
◆ Chief Scientific Officer · Executives · 30 Dec 2022 · CEL SCI CORP 1,021 shares @ US$2.35 0.7% of flow Common Stock SEC:0001236215-23-000003:0
◆ Chief Scientific Officer · Executives · 30 Sept 2022 · CEL SCI CORP 776 shares @ US$3.09 0.7% of flow Common Stock SEC:0001236215-22-000007:0
◆ Chief Scientific Officer · Executives · 30 Jun 2022 · CEL SCI CORP 533 shares @ US$4.50 0.7% of flow Common Stock SEC:0001236215-22-000003:0
◆ Chief Scientific Officer · Executives · 31 Mar 2022 · CEL SCI CORP 610 shares @ US$3.93 0.0029% mcap 0.7% of flow Common Stock SEC:0001236030-22-000007:0
◆ Chief Scientific Officer · Executives · 31 Dec 2021 · CEL SCI CORP 338 shares @ US$7.10 0.0029% mcap 0.7% of flow Common Stock SEC:0001236030-22-000003:0
◆ Chief Scientific Officer · Executives · 31 Dec 2021 · CEL SCI CORP 338 shares @ US$7.10 0.6% of flow Common Stock SEC:0001236030-22-000003
▼ Chief Scientific Officer · Executives · 19 Oct 2021 · CEL SCI CORP 15,000 shares @ US$11.25 0.20% mcap 47.6% of flow Common Stock SEC:0001236030-21-000007:0
▼ Chief Scientific Officer · Executives · 19 Oct 2021 · CEL SCI CORP 15,000 shares @ US$11.25 43.7% of flow Common Stock SEC:0001236030-21-000007
◆ Chief Scientific Officer · Executives · 30 Sept 2021 · CEL SCI CORP 218 shares @ US$10.99 0.0028% mcap 0.7% of flow Common Stock SEC:0001236030-21-000005:0
◆ Chief Scientific Officer · Executives · 30 Sept 2021 · CEL SCI CORP 218 shares @ US$10.99 0.6% of flow Common Stock SEC:0001236030-21-000005
◆ Chief Scientific Officer · Executives · 30 Jun 2021 · CEL SCI CORP 276 shares @ US$8.68 0.0027% mcap 0.7% of flow Common Stock SEC:0001282304-21-000007:0
◆ Chief Scientific Officer · Executives · 30 Jun 2021 · CEL SCI CORP 276 shares @ US$8.68 0.6% of flow Common Stock SEC:0001282304-21-000007
◆ Chief Scientific Officer · Executives · 31 Dec 2015 · CEL SCI CORP 6,486 shares Common Stock SEC:0001236031-16-000031:0
About TALOR EYAL Eyal Talor is the Chief Scientific Officer at CEL-SCI Corp. He is responsible for leading the company's research and development initiatives. With expertise in biomedical sciences, he plays a key role in innovation and advancing scientific projects. His leadership is essential in guiding CEL-SCI's research efforts.